Home › Triple-Negative Breast Cancer › California › Santa Monica
Triple-Negative Breast Cancer clinical trials in Santa Monica, CA
6 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Santa Monica (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- UCLA Medical Center, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Kivu Trial Site, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 mi away
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecruitingPhase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RecruitingPhase 1/2
- NextGen Oncology, Beverly Hills · 6 mi away
A Beta-only IL-2 ImmunoTherapY Study
RecruitingPhase 1/2
- Providence Saint John's Health Center, Santa Monica
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Santa Monica
- Non-Small Cell Lung Cancer45 studies
- Breast Cancer28 studies
- Colorectal Cancer23 studies
- Cancer (all types)22 studies
- Metastatic Cancer19 studies
- Lung Cancer15 studies
- Ovarian Cancer15 studies
- Prostate Cancer15 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure11 studies
- Endometrial Cancer10 studies
- Stomach Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.